Author Archives: Steve Walker

Immuno-oncology conundrum: Stage IV patient wants cutting-edge immunotherapy, but his oncologist says no. My personal take.

The News: Four women had an extremely rare, aggressive and fatal type of ovarian cancer. There was no standard treatment. All four women, who lived in different countries, asked their… Read more »

Study says physical fitness tied to 90% drop in women’s dementia risk; that’s great, but don’t overdo it, others caution.

The News: Highly fit women in midlife were nearly 90% less likely to have dementia decades later, a prospective study in Sweden found. Over 44 years of follow-up, the adjusted… Read more »

Biotech IPOs rock in 2018. More are storming into the queue.

Steve’s Take: Cutting-edge biotech startups and more established privately-funded but publicly held hopefuls are far and away the winners of the race for deep-pocket investors since New Year’s. I thought… Read more »

Under the radar: Uber launches health platform to get patients to and from appointments–whether or not they have the app or a smartphone!

The News: UBER Technologies Inc. (San Francisco) is launching a new business line called Uber Health that will provide a ride-hailing platform available specifically to healthcare providers, letting clinics, hospitals,… Read more »

Warren Buffett’s bluster about new healthcare venture bound to backfire. Then what?

The News: Warren Buffett says his joint venture with Jeff Bezos and Jamie Dimon is going for something bigger than shaving a few percentage points off healthcare costs. The big… Read more »

Study finds working the graveyard shift can have more serious health consequences than previously thought. New data should support better compensation.

The News: Night-shift work may wreak havoc with blood-sugar levels, a new study asserts. Researchers analyzed data on more than 270,000 people in the United Kingdom and found that those… Read more »

New study says family history increases breast-cancer risk, even among older women. US mammogram guidelines need updating–soon.

The News: Women are more likely to develop breast cancer when a mother or sister had this disease, and the risk associated with family history doesn’t diminish regardless of age,… Read more »

South Korea’s Celltrion Inc. (Incheon) gets EU green light for Herceptin biosimilar

The News: Celltrion Inc. said on February 14, 2018 that it has received approval to sell its replica version of Roche Holding AG’s (Basel CHE) breast-cancer blockbuster Herceptin in Europe…. Read more »

Join a clinical trial? The success rate of such trials is higher than you thought, but still awfully low overall; especially for Alzheimer’s.

The News: Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trial–which still suggests that it’s… Read more »